context diabetic retinopathy dr is the leading cause of blindness in the workingaged population in the united statesthere are many new interventions for dr but evidence to support their use is uncertainobjective to review the best evidence for primary and secondary intervention in the management of dr including diabetic macular edemaevidence acquisition systematic review of all englishlanguage articles retrieved using a keyword search of medline 1966 through may 2007 embase cochrane collaboration the association for research in vision and ophthalmology database and the national institutes of health clinical trials database and followed by manual searches of reference lists of selected major review articlesall englishlanguage randomized controlled trials rcts with more than 12 months of followup and metaanalyses were includeddelphi consensus criteria were used to identify wellconducted studiesevidence synthesis fortyfour studies including 3 metaanalyses met the inclusion criteriatight glycemic and blood pressure control reduces the incidence and progression of dr panretinal laser photocoagulation reduces the risk of moderate and severe visual loss by 50 in patients with severe nonproliferative and proliferative retinopathyfocal laser photocoagulation reduces the risk of moderate visual loss by 50 to 70 in eyes with macular edemaearly vitrectomy improves visual recovery in patients with proliferative retinopathy and severe vitreous hemorrhageintravitreal injections of steroids may be considered in eyes with persistent loss of vision when conventional treatment has failedthere is insufficient evidence for the efficacy or safety of lipidlowering therapy medical interventions or antivascular endothelial growth factors on the incidence or progression of drconclusions tight glycemic and blood pressure control remains the cornerstone in the primary prevention of dr panretinal and focal retinal laser photocoagulation reduces the risk of visual loss in patients with severe dr and macular edema respectivelythere is currently insufficient evidence to recommend routine use of other treatments